Home › Free Stock Grades › PCRX
Pacira BioSciences, Inc. (PCRX) Stock Grade
PCRX · Healthcare
A
Market Cap
$1.2B
P/E Ratio
164.0
Revenue Growth (YoY)
+3.6%
Net Margin
1.0%
Return on Equity
1.0%
Dividend Yield
None
About Pacira BioSciences, Inc.'s fundamentals
Pacira BioSciences is a specialty pharmaceutical company with a market capitalization of $1.2 billion that generated modest revenue growth of 3.6% year-over-year, though profitability metrics reveal significant challenges. The company's net margin of 1.0% and return on equity of 1.0% indicate minimal profit generation relative to sales and shareholder investment, while the elevated P/E ratio of 164.0 suggests the stock price is substantially high compared to current earnings. The company does not currently pay a dividend to shareholders.